CORRECTION: The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners

CORRECTION: The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners

...

The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners

The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners

...

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

...

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound

Io Therapeutics, Inc., announces presentation of data on induction of tumor growth inhibiting anti-cancer immune responses in multiple types of cancers by a IRX5010, a novel retinoic acid nuclear receptor agonist compound

...

AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer

AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001 Administration in Patients with Nonmelanoma Skin Cancer

...

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors

...

Aztiq and Innobic Announce Pricing of Secondary Sale of Lotus Common Stock by AEMH

Aztiq and Innobic Announce Pricing of Secondary Sale of Lotus Common Stock by AEMH

...

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101

NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce Collaboration to Develop and Commercialize NRX-101

...

Global talent leader WilsonHCG announces integration of Profile and Personify brands 

Global talent leader WilsonHCG announces integration of Profile and Personify brands 

...

Hyloris reports full year results for 2022 & provides

Hyloris reports full year results for 2022 & provides

Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing dealsPotential U.S. market approval for......

    •
  • 1
  • 2
    •
    menu
    menu